Suprachoroidal Injection of Triamcinolone Acetonide Injectable Suspension for the Treatment of Macular Edema Associated With Uveitis in the United States: A Cost-Effectiveness Analysis.

Suprachoroidal Injection of Triamcinolone Acetonide Injectable Suspension for the Treatment of Macular Edema Associated With Uveitis in the United States: A Cost-Effectiveness Analysis. Value Health. 2022 10; 25(10):1705-1716.

View in: PubMed

subject areas

Aged
Cost-Benefit Analysis
Glucocorticoids
Humans
Macular Edema
Medicare
Quality of Life
Treatment Outcome
Triamcinolone Acetonide
United States
Uveitis
Visual Acuity

authors with profiles

Seenu Hariprasad